Weight-based vancomycin loading strategy may not improve achievement of optimal vancomycin concentration in patients with preserved renal function
- 23 April 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 33 (1) , 56-61
Abstract
We performed a retrospective study to evaluate clinical effectiveness of vancomycin loading strategy and factors associated with achieving optimal Cmin. Patients administered vancomycin for ≥72 h from January to June 2018 were enrolled. Patients were divided into two groups: loading (LD) and non-loading (NLD). LD was defined as initial vancomycin dose ≥20 mg/kg and ≥120% of maintenance dose. During study period, 70 and 71 received initial LD (24.2 ± 2.5 mg/kg) and NLD (17.3 ± 3.3 mg/kg) doses of vancomycin, respectively (p < .001). Achievement of optimal Cmin was not different before administration of the third dose (24.4% in LD versus 18.2% in NLD, p = .484) and within 72 h (22.9% versus 28.2%, p = .759). Risk factors for failure to achieve optimal Cmin before administration of the third dose were higher creatinine clearance and higher level of serum albumin. Therefore, more sufficient loading or patient-specific dose strategies should be used to achieve optimal serum vancomycin Cmin.Keywords
Funding Information
- Ministry of Trade, Industry & Energy
- Industrial Technology Innovation Program (10080648)
This publication has 20 references indexed in Scilit:
- Vancomycin Pharmacokinetics Throughout Life: Results from a Pooled Population Analysis and Evaluation of Current Dosing RecommendationsClinical Pharmacokinetics, 2019
- Optimizing the Clinical Use of VancomycinAntimicrobial Agents and Chemotherapy, 2016
- Trough Concentration Over 12.1 mg/L is a Major Risk Factor of Vancomycin-Related Nephrotoxicity in Patients With Therapeutic Drug MonitoringTherapeutic Drug Monitoring, 2014
- Evaluation of a vancomycin dosing nomogram based on the Modification of Diet in Renal Disease equation in intensive care unit patientsJournal of Critical Care, 2013
- Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levelsInternal Medicine Journal, 2012
- Use of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infectionsExpert Review of Anti-infective Therapy, 2010
- Relationship between Initial Vancomycin Concentration‐Time Profile and Nephrotoxicity among Hospitalized PatientsClinical Infectious Diseases, 2009
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsClinical Infectious Diseases, 2009
- Vancomycin: A 50-Year ReassessmentClinical Infectious Diseases, 2006
- Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract InfectionsClinical Pharmacokinetics, 2004